UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Deregulation of HLA-I in cancer and its central importance for immunotherapy

Journal for immunotherapy of cancer, 2021-08, Vol.9 (8), p.e002899

2021

Volltextzugriff (PDF)

The role of cancer metabolism in defining the success of oncolytic viro-immunotherapy

Cytokine & growth factor reviews, 2020-12, Vol.56, p.115-123

2020

Volltextzugriff (PDF)

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial

The Lancet (British edition), 2014-03, Vol.383 (9923), p.1129-1137

2014

Volltextzugriff (PDF)

Polymer coatings for delivery of nucleic acid therapeutics

Journal of controlled release, 2012-07, Vol.161 (2), p.537-553

2012

Volltextzugriff (PDF)

Making Oncolytic Virotherapy a Clinical Reality: The European Contribution

Human gene therapy, 2017-11, Vol.28 (11), p.1033-1046

2017

Volltextzugriff (PDF)

Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.320-320, Article 320

2019

Volltextzugriff (PDF)

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Journal for immunotherapy of cancer, 2017-09, Vol.5 (1), p.71-71, Article 71

2017

Volltextzugriff (PDF)

Use of Liquid Patient Ascites Fluids as a Preclinical Model for Oncolytic Virus Activity

Methods in molecular biology (Clifton, N.J.), 2020-01, Vol.2058, p.261

2020

Volltextzugriff (PDF)

Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion

Cancers, 2020-04, Vol.12 (4), p.851

2020

Volltextzugriff (PDF)

Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes

Journal of controlled release, 2014-03, Vol.178, p.101-107

2014

Volltextzugriff (PDF)

Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1

Proceedings of the National Academy of Sciences - PNAS, 2009-11, Vol.106 (47), p.19940-19945

2009

Volltextzugriff (PDF)

Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference

Cancer gene therapy, 2019-03, Vol.26 (3-4), p.59-73

2019

Volltextzugriff (PDF)

External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase

Cancers, 2020-03, Vol.12 (4), p.798

2020

Volltextzugriff (PDF)

Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus

Molecular therapy. Oncolytics, 2017-06, Vol.5 (C), p.62-74

2017

Volltextzugriff (PDF)

Directed evolution generates a novel oncolytic virus for the treatment of colon cancer

PloS one, 2008-06, Vol.3 (6), p.e2409-e2409

2008

Volltextzugriff (PDF)

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus

Molecular therapy. Oncolytics, 2021-06, Vol.21, p.47-61

2021

Volltextzugriff (PDF)

Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation

Molecular therapy. Oncolytics, 2019-12, Vol.15, p.117-130

2019

Volltextzugriff (PDF)

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells

Journal for immunotherapy of cancer, 2018-06, Vol.6 (1), p.55-55, Article 55

2018

Volltextzugriff (PDF)

Virotherapy – cancer targeted pharmacology

Drug discovery today, 2012-03, Vol.17 (5-6), p.215-220

2012

Volltextzugriff (PDF)

OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution

Molecular therapy. Oncolytics, 2017-03, Vol.4 (C), p.55-66

2017

Volltextzugriff (PDF)

Adenovirus: teaching an old dog new tricks

Human gene therapy, 2011-09, Vol.22 (9), p.1041-1042

2011

Volltextzugriff (PDF)

MEN1 Gene Replacement Therapy Reduces Proliferation Rates in a Mouse Model of Pituitary Adenomas

Cancer research (Chicago, Ill.), 2012-10, Vol.72 (19), p.5060-5068

2012

Volltextzugriff (PDF)

Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo

Bioconjugate chemistry, 1992-09, Vol.3 (5), p.351-362

1992

Volltextzugriff (PDF)

Light and Color in the Outdoors

1st ed. 1993. Corr. 2nd printing 1995, 1993

Volltextzugriff (PDF)

The British Society for Gene and Cell Therapy at 20 (2003-2023)

Human gene therapy, 2024-01, Vol.35 (1-2), p.5-8

2024

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(54)
Bücher
(1)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Deregulation of HLA-I in cancer and its central importance for immunotherapy

The role of cancer metabolism in defining the success of oncolytic viro-immunotherapy

Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial

Polymer coatings for delivery of nucleic acid therapeutics

Making Oncolytic Virotherapy a Clinical Reality: The European Contribution

Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples

Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Use of Liquid Patient Ascites Fluids as a Preclinical Model for Oncolytic Virus Activity

Attenuation of the Hypoxia Inducible Factor Pathway after Oncolytic Adenovirus Infection Coincides with Decreased Vessel Perfusion

Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug from intravenously delivered liposomes

Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1

Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference

External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase

Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus

Directed evolution generates a novel oncolytic virus for the treatment of colon cancer

Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus

Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKCα Activation

Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells

Virotherapy – cancer targeted pharmacology

OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution

Adenovirus: teaching an old dog new tricks

MEN1 Gene Replacement Therapy Reduces Proliferation Rates in a Mouse Model of Pituitary Adenomas

Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo

Light and Color in the Outdoors

The British Society for Gene and Cell Therapy at 20 (2003-2023)

Suchergebnisse filtern